Clinical benefits of miglustat on bone disease in adult type 1 Gaucher disease (GD1): A meta-analysis

被引：0
|
作者：
Pastores, G. M.
Elstein, D.
Hrebicek, M.
Zimran, A.
机构：
[1] NYU, Sch Med, Dept Neurol & Pediat, New York, NY USA
[2] Shaare Zedek Med Ctr, Dept Med, IL-91000 Jerusalem, Israel
[3] Inst IMD, Prague, Czech Republic
来源：
CALCIFIED TISSUE INTERNATIONAL | 2007年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S68 / S68
页数：1
相关论文
共 50 条
  • [1] Clinical effects of miglustat on bone disease in adult type I Gaucher disease: A meta-analysis
    Pastores, Gregory
    Elstein, Deborah
    Hrebicek, Martin
    Zimram, Ari
    MOLECULAR GENETICS AND METABOLISM, 2008, 93 (02) : S45 - S46
  • [2] Post-marketing surveillance of miglustat in type 1 Gaucher disease (GD1)
    Hughes, D. A.
    Hollak, C. E. M.
    Schwierin, B.
    Bembi, B.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 119 - 119
  • [3] Prevalence of polyneuropathy in adult type 1 Gaucher disease (GD1): A multinational prospective observational study
    Hollak, C. E. M.
    Biegstraaten, M.
    Van Schaik, I. N.
    Mengel, E.
    Marodi, L.
    Petakov, M.
    Niederau, C.
    Giraldo, P.
    Hughes, D.
    Mrsic, M.
    Mehta, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2007, 30 : 107 - 107
  • [4] Demography of untreated Type 1 Gaucher disease (GD1) in children.
    Kaplan, P
    Andersson, HC
    Charrow, J
    Prakash-Cheng, A
    Kolodny, EH
    Mistry, P
    Pastores, GM
    Rosenbloom, B
    Scott, CR
    Wappner, RS
    Weinreb, N
    AMERICAN JOURNAL OF HUMAN GENETICS, 2003, 73 (05) : 456 - 456
  • [5] Population pharmacokinetics of eliglustat in patients with Gaucher Disease Type 1 (GD1)
    Lu, Qiang
    Gao, Yue
    Li, Jing
    Kanamaluru, Vanaja
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S127 - S128
  • [6] Occurrence of multiple cancers in type I Gaucher disease (GD1)
    Lo, Sarah
    Stein, Philip
    Yang, Ruhua
    Mistry, Pramod
    MOLECULAR GENETICS AND METABOLISM, 2010, 99 (02) : S25 - S25
  • [7] ADULT PATIENTS WITH TYPE I GAUCHER DISEASE (GD 1) ON LONG-TERM MIGLUSTAT TREATMENT
    Hollak, C.
    Heitner, R.
    Hrebicek, M.
    Elstein, D.
    Zimran, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 171 - 171
  • [8] Treatment by miglustat of a young adult presenting type 1 Gaucher's disease
    Djerad, Hama
    PRESSE MEDICALE, 2006, 35 : S33 - S34
  • [9] Validation study of a DS3 severity score index for adult patients with type 1 Gaucher disease (GD1)
    Weinreb, Neal J.
    Finegold, David
    Feingold, Eleanor
    Rosenbloom, Barry
    Shankar, Suma
    Amato, Dominick
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S112 - S113
  • [10] Beneficial effects of miglustat on skeletal symptoms in type I Gaucher disease: A meta-analysis
    Pastores, Greg
    Elstein, D.
    Hrebicek, M.
    Zimran, A.
    MOLECULAR GENETICS AND METABOLISM, 2007, 92 (04) : S16 - S17
12345